Lyra Therapeutics Inc (LYRA)
0.2758
+0.01
(+2.02%)
USD |
NASDAQ |
Jun 24, 09:47
Lyra Therapeutics Total Liabilities (Quarterly): 64.02M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.02M |
| December 31, 2023 | 53.18M |
| September 30, 2023 | 36.34M |
| June 30, 2023 | 27.10M |
| March 31, 2023 | 27.78M |
| December 31, 2022 | 29.21M |
| September 30, 2022 | 26.24M |
| June 30, 2022 | 19.00M |
| March 31, 2022 | 19.19M |
| Date | Value |
|---|---|
| December 31, 2021 | 20.55M |
| September 30, 2021 | 20.57M |
| June 30, 2021 | 18.83M |
| March 31, 2021 | 5.366M |
| December 31, 2020 | 6.338M |
| September 30, 2020 | 6.416M |
| June 30, 2020 | 5.90M |
| March 31, 2020 | 167.55M |
| December 31, 2019 | 138.30M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.366M
Minimum
Mar 2021
167.55M
Maximum
Mar 2020
38.44M
Average
23.41M
Median
Total Liabilities (Quarterly) Benchmarks
| Integra Lifesciences Holdings Corp | 2.480B |
| Perspective Therapeutics Inc | 48.40M |
| Electromed Inc | 6.357M |
| Xtant Medical Holdings Inc | 46.25M |
| Asensus Surgical Inc | 27.79M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.53M |
| Shareholders Equity (Quarterly) | 77.50M |
| Current Ratio | 4.777 |